CapeBio Technologies intends to develop a state-of-the-art AI platform to mine metagenomic data for novel antimicrobial peptide genes. This is a machine-learning and data-science-driven application that allows for better and novel detection of medically important genes that can be used to fight diseases such as cancer and tuberculosis.